L?Arginine Hydrochloride & Glucose Injection 10?g + 25?g (Kangsikowe)

L?Arginine Hydrochloride & Glucose Injection 10?g + 25?g (Kangsikowe)

$2.00

This sterile injection delivers 10?g L?arginine HCl and 25?g glucose per 500?ml bottle. Manufactured by Sichuan Kelun Pharmaceutical Co., Ltd. and approved under NMPA H20040530. Ideal for preclinical studies on hyperammonemia, hepatic encephalopathy, urea cycle disorders, and ammonia metabolism.
?? For laboratory and research use only.?Please consult staff for other specifications and uses?

EMI starting from $0.00/month - View Plans
Compare

描述

L?Arginine HCl combined with glucose supports detoxification by activating the urea cycle, facilitating hepatic ammonia clearance. The glucose portion supplies energy substrates, offsetting the catabolic stress during hepatic dysfunction. Primarily used in animal models of hepatic encephalopathy and acute hyperammonemia to study neuroprotection and detoxification pathways.


L?Arginine Hydrochloride & Glucose Product Specifications

Parameter Details
Product Name L?Arginine Hydrochloride & Glucose Injection (Kangsikowe)
Active Ingredients L?Arginine HCl 10?g; Glucose 25?g
CAS Numbers Arginine HCl: –; Glucose: –
Formulation Sterile aqueous injection, 500?ml bottle
Strength 10?g + 25?g per 500?ml
Dosage Form Injection (500?ml infusion)
Approval No. H20040530
Drug Standard Code 86902180001467
Manufacturer Sichuan Kelun Pharmaceutical Co., Ltd.
Packaging 500?ml glass bottle × 1
Storage Conditions Room temperature storage, protect from light and contamination
Intended Use Lab research: hyperammonemia, hepatic encephalopathy, ammonia detox models

L?Arginine Hydrochloride & Glucose Mechanism of Action

Arginine is a substrate in the urea cycle, converting ammonia into urea. Combined with glucose, it optimizes detoxification and energy supply in acute liver injury and ammonia metabolism. This formulation is used in models of hepatic encephalopathy and urea cycle dysfunction.


L?Arginine Hydrochloride & Glucose Research Application Areas

  • Hepatic encephalopathy models: ammonia detox via urea cycle

  • Hyperammonemia studies

  • Ammonia metabolism & neuroprotection assays

  • Glucose support in liver failure models


Safety & Handling

  • Dosage in models: 15–20?g arginine IV over 4 hours for ammonia-lowering studies

  • Side Effects: Generally mild; monitor glucose and electrolytes.

  • Contraindications: Sodium-sensitive conditions, severe hyperglycemia, arginine hypersensitivity.

  • Storage: Keep sealed at room temperature, away from light.

  • Handling: Use under lab protocols with standard aseptic technique.


Core Keywords

L-arginine glucose injection, arginine HCl glucose 10g+25g, ammonia detox injection, hyperammonemia research, hepatic encephalopathy model, H20040530, lab-grade arginine glucose infusion


Research Use Disclaimer

This product is intended exclusively for laboratory and preclinical research use. It is not approved for clinical, therapeutic, diagnostic, or veterinary use. Misuse may pose health or regulatory risks. Use only under institutional protocols.

其他信息

重量 1.2 公斤
尺寸 28 × 23 × 28 厘米

评价

目前还没有评价

成为第一个“L?Arginine Hydrochloride & Glucose Injection 10?g + 25?g (Kangsikowe)” 的评价者

您的邮箱地址不会被公开。 必填项已用 * 标注

EMI Options

Select at least 2 products
to compare